[A trial of hormonochemotherapy of prostate cancer].
Four hundred mg of UFT and 100 mg of cyclophosphamide were orally administered to patients with prostate cancer, additional to conventional hormone therapy. Four cases are presented here, all of whom showed good response to the therapy.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil; D004054:Diethylstilbestrol; D003520:Cyclophosphamide; C004955:fosfestrol